The Effect of Oxytocin on Face Perception

Early Phase 1SuspendedNCT02091817

Soroka University Medical Center100 enrolled

Overview

The purpose of this study is to determine whether oxytocin affect face perception

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

DOUBLE

Enrollment

100

Conditions

Healthy Congenital Prosopagnosia

Interventions

OxytocinDRUG

Intervention will be examined on control group, and on experimental group as well.

PlaceboDRUG

Placebo will be given to control group and experimental group as well.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * normal or corrected to normal vision Exclusion Criteria: * minors * pregnancy (according to a pregnancy test taken by subjects prior to participation) * a history of asthma or nasal polyps * cardiac disorders * hyponatremia * acute or chronic renal insufficiency * liver cirrhosis * neurological disease * other chronic disease * dementia, or lack of judgment

Locations (1)

Soroka medical center

Beersheba, Israel, Israel

Outcomes

Primary Outcomes

Memory performance

At the day participants will administer the substance, they will view a set of faces, of which they will be tested about 24 hours later. The measures that will be tested are %accuracy and %dwell time of eye movements towards each region in the faces the participants saw.

Time frame: Day 2 (24 hours after encoding)

Secondary Outcomes

Mood measurement

Participants will fill a PANAS mood questionnaire in order to monitor the effects of mood and fatigue of oxytocin/placebo. We will use ANOVA on the total score of the test in order to verify that differences in performance are not due to change in mood or fatigue after substance uptake.

Time frame: Day 1 (after oxytocin/placebo uptake)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.